PRE-BRONCHIOLITIS OBLITERANS SYNDROME

Clinical trials for PRE-BRONCHIOLITIS OBLITERANS SYNDROME explained in plain language.

Never miss a new study

Get alerted when new PRE-BRONCHIOLITIS OBLITERANS SYNDROME trials appear

Sign up with your email to follow new studies for PRE-BRONCHIOLITIS OBLITERANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New inhaled therapy aims to stop lung transplant failure

Disease control Recruiting now

This study tests an inhaled drug called ARINA-1 in 100 people who have had a double lung transplant and show early signs of lung decline. The goal is to see if adding ARINA-1 to standard care can prevent or slow down a serious condition called bronchiolitis obliterans syndrome (B…

Matched conditions: PRE-BRONCHIOLITIS OBLITERANS SYNDROME

Phase: PHASE3 • Sponsor: Renovion, Inc. • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

PRE-BRONCHIOLITIS OBLITERANS SYNDROME

Get alerted when new PRE-BRONCHIOLITIS OBLITERANS SYNDROME trials appear

New inhaled therapy aims to stop lung transplant failure